What Does Evidence Tell us about T2D Approach? Dr. Adrián Proietti - Endocrinologist - Argentina
About the event
In his video, Dr. A. Proietti, reviews the different treatments available to patients with DM2 (Sulfonylureas, DPP4 inhibitors and SGLT2 inhibitors), showing the efficacy and safety data provided by each of these therapies. The doctor concludes by highlighting the protection provided by Gliclazide MR, a modern sulfonylurea - and different from those of its group - which offers patients superior control of HbA1c, with an excellent safety profile and cardiovascular and renal protection demonstrated in various clinical studies.
Don't miss our next events!
Subscribe to our newsletter to receive invitations to upcoming events
You can unsubscribe at any time by clicking on the link in our emails.